Reporting Amount of Listed Drugs and Biological Products Under Section 510(j)(3) of the Federal Food, Drug, and Cosmetic Act; Draft Guidance for Industry

Procedural Guidance

Source: FDA Center for Drug Evaluation and Research - What's New - October 29, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news